Ndrepepa Gjin, Guerra Elena, Schulz Stefanie, Hoppmann Petra, Laugwitz Karl-Ludwig, Kastrati Adnan
aDeutsches Herzzentrum, München b1.Medizinische Klinik rechts der Isar, Technische Universität cDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Coron Artery Dis. 2014 Sep;25(6):456-62. doi: 10.1097/MCA.0000000000000126.
The objective of this study was to identify factors associated with the increased risk of mortality among patients with bleeding complications during percutaneous coronary intervention (PCI).
The study included 1510 patients with periprocedural bleeding complications of the 14 180 patients undergoing PCI. Bleeding was defined and scaled according to the Bleeding Academic Research Consortium criteria. The main outcome was all-cause mortality at 1 year after PCI.
Of the 1510 patients with bleeding within the first 30 days of PCI, 104 patients (6.9%) died during the first year after PCI. One-year survival according to the Bleeding Academic Research Consortium classes was as follows: 96.4% (22 deaths) in class 1, 94.7% (12 deaths) in class 2, 91.0% (42 deaths) in class 3a, 85.4% (23 deaths) in class 3b, and 58.3% (five deaths) in class 3c (P<0.001). The Cox proportional hazards model identified bleeding severity [hazard ratio (HR)=1.55, 95% confidence interval 1.25-1.93 for one class increase in bleeding scale, P<0.001], bleeding site [HR=1.79 (1.18-2.71) for nonaccess vs. access site, P=0.006], elevated troponin levels [HR=1.66 (1.09-2.53), P=0.018], multivessel disease [HR=2.15 (1.01-4.56), P=0.047], C-reactive protein [HR=1.04 (1.01-1.06) for 5 mg/l increase, P=0.002], anemia [HR=2.27 (1.39-3.71) for 4 g/dl decrease in hemoglobin, P=0.001], and platelet count [HR=1.11 (1.02-1.21) for 50×10/l increase in platelet count, P=0.013] as independent associates of mortality. Age (P=0.072) and reduced estimated creatinine clearance (P=0.066) were close to reaching statistical significance as associates of mortality.
Among patients with peri-PCI bleeding, the characteristics of bleeding itself and the cardiovascular risk profile underlie the increased risk for poor outcome after PCI.
本研究的目的是确定经皮冠状动脉介入治疗(PCI)期间出血并发症患者死亡风险增加的相关因素。
该研究纳入了14180例接受PCI治疗患者中的1510例围手术期出血并发症患者。根据出血学术研究联盟标准对出血进行定义和分级。主要结局是PCI术后1年的全因死亡率。
在PCI术后前30天内出血的1510例患者中,104例(6.9%)在PCI术后第一年内死亡。根据出血学术研究联盟分级的1年生存率如下:1级为96.4%(22例死亡),2级为94.7%(12例死亡),3a级为91.0%(42例死亡),3b级为85.4%(23例死亡),3c级为58.3%(5例死亡)(P<0.001)。Cox比例风险模型确定出血严重程度[风险比(HR)=1.55,出血分级每增加一级,95%置信区间为1.25 - 1.93,P<0.001]、出血部位[非穿刺部位与穿刺部位相比,HR=1.79(1.18 - 2.71),P=0.006]、肌钙蛋白水平升高[HR=1.66(1.09 - 2.53),P=0.018]、多支血管病变[HR=2.15(1.01 - 4.56),P=0.047]、C反应蛋白[每增加5mg/l,HR=1.04(1.01 - 1.06),P=0.002]、贫血[血红蛋白每降低4g/dl,HR=2.27(1.39 - 3.71),P=0.001]以及血小板计数[血小板计数每增加50×10⁹/l,HR=1.11(1.02 - 1.21),P=0.013]是死亡的独立相关因素。年龄(P=0.072)和估算的肌酐清除率降低(P=0.066)作为死亡相关因素接近具有统计学意义。
在PCI围手术期出血的患者中,出血本身的特征和心血管风险状况是PCI术后不良结局风险增加的基础。